Although cardiac resynchronization therapy (CRT) has become well established in the treatment of heart failure, the management of patients who do not respond after CRT remains a key challenge. This review will summarize what we have learned about non-responders over the last 20 years and discuss methods for optimizing response, including the introduction of novel therapies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ccep.2021.12.019 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!